Conversely, in urinary bladder urothelial carcinoma, cutaneous melanoma, nasopharyngeal cancer, and B-cell lymphoma, EMP2 overexpression suppresses the viability and proliferation of cancer cells, functioning as a tumor suppressor [30–33]. Here, EMP2 is linked to nasopharyngeal carcinoma.